NEK Biosciences Overview

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

NEK Biosciences General Information

Description

Developer of regenerative medicine products designed for wound healing in animals. The company offers collagen-based formulations for treating tissue damage, enabling agricultural users to improve animal health and reduce productivity loss.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 159 Willoughby Lake Road
  • Barton, VT 05822
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 159 Willoughby Lake Road
  • Barton, VT 05822
  • United States

NEK Biosciences Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NEK Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 06-Apr-2026 Completed Startup
2. Grant 01-Jan-2025 Completed Startup
1. Grant 01-Jan-2024 $10K Completed Startup
To view NEK Biosciences’s complete valuation and funding history, request access »

NEK Biosciences Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
LaunchVT Accelerator/Incubator
University of Vermont University
To view NEK Biosciences’s complete investors history, request access »

NEK Biosciences FAQs

  • Where is NEK Biosciences headquartered?

    NEK Biosciences is headquartered in Barton, VT.

  • What industry is NEK Biosciences in?

    NEK Biosciences’s primary industry is Biotechnology.

  • Is NEK Biosciences a private or public company?

    NEK Biosciences is a Private company.

  • What is NEK Biosciences’s current revenue?

    The current revenue for NEK Biosciences is .

  • Who are NEK Biosciences’s investors?

    LaunchVT and University of Vermont have invested in NEK Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process